Major beta blocker mortality trials in chronic heart failure: a critical review
- 1 December 1999
- Vol. 82 (Supplement) , 14iv-22
- https://doi.org/10.1136/hrt.82.2008.iv14
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart FailureNew England Journal of Medicine, 1998
- Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparisonEuropean Heart Journal, 1998
- Safety and efficacy of carvedilol in severe heart failureJournal of Cardiac Failure, 1997
- Effect of Beta-Blockade on Mortality in Patients With Heart Failure: A Meta-Analysis of Randomized Clinical TrialsJournal of the American College of Cardiology, 1997
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)Published by Elsevier ,1997
- The Effect of Digoxin on Mortality and Morbidity in Patients with Heart FailureNew England Journal of Medicine, 1997
- Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991